Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation

Frontiers in Genetics

Volumn 5, Issue FEB, 2014, Pages

  Katsushima, Keisuke ^a   Kondo, Yutaka ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cancer stem cells; Epigenetics; Glioma; Long non coding RNA; Micro RNA

Indexed keywords

BETA CATENIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE 6; MICRORNA; MICRORNA 124; MICRORNA 1275; MICRORNA 128; MICRORNA 137; MICRORNA 138; MICRORNA 17 92; MICRORNA 204; MICRORNA 302 327 CLUSTER; MICRORNA 34A; MICRORNA 451; NOTCH RECEPTOR; POLYPYRIMIDINE TRACT BINDING PROTEIN; PROTEIN P53; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; UNTRANSLATED RNA; WNT PROTEIN;

APOPTOSIS; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GENETIC REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; IMMUNOPRECIPITATION; RADIOSENSITIVITY; RECEPTOR DOWN REGULATION; RNA SPLICING; SHORT SURVEY; TUMOR DIFFERENTIATION;

EID: 84897731251     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00014     Document Type: Short Survey

References (105)

1. Abdouh, M., Facchino, S., Chatoo, W., Balasingam, V., Ferreira, J., and Bernier, G. (2009). BMI1 sustains human glioblastoma multiforme stem cell renewal. J. Neurosci. 29, 8884-8896. doi: 10.1523/JNEUROSCI.0968-09.2009.
2. Ambros, V., and Lee, R. C. (2004). Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol. Biol. 265, 131-158. doi: 10.1385/1-59259-775-0131.
3. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. doi: 10.1016/S0092-8674(04)00045-5.
4. Birney, E., Stamatoyannopoulos, J. A., Dutta, A., Guigo, R., Gingeras, T. R., Margulies, E. H., et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816. doi: 10.1038/nature05874.
5. Braconi, C., Valeri, N., Kogure, T., Gasparini, P., Huang, N., Nuovo, G. J., et al. (2011). Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 108, 786-791. doi: 10.1073/pnas.1011098108.
6. Calin, G. A., Liu, C. G., Ferracin, M., Hyslop, T., Spizzo, R., Sevignani, C., et al. (2007). Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215-229. doi: 10.1016/j.ccr.2007.07.027.
7. Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M., et al. (2011). A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369. doi: 10.1016/j.cell.2011.09.028.
8. Chan, X. H., Nama, S., Gopal, F., Rizk, P., Ramasamy, S., Sundaram, G., et al. (2012). Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas. Cell Rep. 2, 591-602. doi: 10.1016/j.celrep.2012.07.012.
9. Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., et al. (2011). Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 102, 245-252. doi: 10.1111/j.1349-7006.2010.01737.x.
10. Clement, V., Sanchez, P., De Tribolet, N., Radovanovic, I., and Ruiz I Altaba, A. (2007). HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17, 165-172. doi: 10.1016/j.cub.2006.11.033.
11. Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775-1789. doi: 10.1101/gr.132159.111.
12. Ellis, B. C., Molloy, P. L., and Graham, L. D. (2012). CRNDE:a long non-coding RNA involved in cancer, neurobiology, and development. Front. Genet. 3:270. doi: 10.3389/fgene.2012.00270.
13. Ernst, A., Campos, B., Meier, J., Devens, F., Liesenberg, F., Wolter, M., et al. (2010). De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 29, 3411-3422. doi: 10.1038/onc.2010.83.
14. Esteller, M. (2011). Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874. doi: 10.1038/nrg3074.
15. Fan, X., Khaki, L., Zhu, T. S., Soules, M. E., Talsma, C. E., Gul, N., et al. (2010). NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28, 5-16. doi: 10.1002/stem.254.
16. Fan, X., Matsui, W., Khaki, L., Stearns, D., Chun, J., Li, Y. M., et al. (2006). Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66, 7445-7452. doi: 10.1158/0008-5472.CAN-06-0858.
17. Fareh, M., Turchi, L., Virolle, V., Debruyne, D., Almairac, F., De-La-Forest Divonne, S., et al. (2012). The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ. 19, 232-244. doi: 10.1038/cdd.2011.89.
18. Fomchenko, E. I., and Holland, E. C. (2007). Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment. Neurosurg. Clin. N. Am. 18, 39-58; viii. doi: 10.1016/j.nec.2006.10.006.
19. Gabory, A., Ripoche, M. A., Yoshimizu, T., and Dandolo, L. (2006). The H19 gene: regulation and function of a non-coding RNA. Cytogenet. Genome Res. 113, 188-193. doi: 10.1159/000090831.
20. Gal, H., Pandi, G., Kanner, A. A., Ram, Z., Lithwick-Yanai, G., Amariglio, N., et al. (2008). MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem. Biophys. Res. Commun. 376, 86-90. doi: 10.1016/j.bbrc.2008.08.107.
21. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., et al. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021. doi: 10.1158/0008-5472.CAN-04-1364.
22. Gangaraju, V. K., and Lin, H. (2009). MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10, 116-125. doi: 10.1038/nrm2621.
23. Godlewski, J., Newton, H., Chiocca, E., and Lawler, S. (2010a). MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ. 17, 221-228. doi: 10.1038/cdd.2009.71.
24. Godlewski, J., Nowicki, M. O., Bronisz, A., Nuovo, G., Palatini, J., De Lay, M., et al. (2010b). MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell 37, 620-632. doi: 10.1016/j.molcel.2010.02.018.
25. Godlewski, J., Nowicki, M. O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., et al. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68, 9125-9130. doi: 10.1158/0008-5472.CAN-08-2629.
26. Guessous, F., Zhang, Y., Kofman, A., Catania, A., Li, Y., Schiff, D., et al. (2010). microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 9, 1031-1036. doi: 10.4161/cc.9.6.10987.
27. Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., et al. (2011). Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633-644. doi: 10.1016/j.cell.2011.07.026.
28. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076. doi: 10.1038/nature08975.
29. Hadjipanayis, C. G., and Van Meir, E. G. (2009). Brain cancer propagating cells: biology, genetics and targeted therapies. Trends Mol. Med. 15, 519-530. doi: 10.1016/j.molmed.2009.09.003.
30. Hu, W., Alvarez-Dominguez, J. R., and Lodish, H. F. (2012). Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep. 13, 971-983. doi: 10.1038/embor.2012.145.
31. Hu, Y. Y., Zheng, M. H., Cheng, G., Li, L., Liang, L., Gao, F., et al. (2011). Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer 11:82. doi: 10.1186/1471-2407-11-82.
32. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., et al. (2010). A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419. doi: 10.1016/j.cell.2010.06.040.
33. Ji, P., Diederichs, S., Wang, W., Boing, S., Metzger, R., Schneider, P. M., et al. (2003). MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041. doi: 10.1038/sj.onc.1206928.
34. Kapranov, P., Willingham, A. T., and Gingeras, T. R. (2007). Genome-wide transcription and the implications for genomic organization. Nat. Rev. Genet. 8, 413-423. doi: 10.1038/nrg2083.
35. Karreth, F. A., Tay, Y., Perna, D., Ala, U., Tan, S. M., Rust, A. G., et al. (2011). In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147, 382-395. doi: 10.1016/j.cell.2011.09.032.
36. Katsushima, K., Shinjo, K., Natsume, A., Ohka, F., Fujii, M., Osada, H., et al. (2012). Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells. J. Biol. Chem. 287, 27396-27406. doi: 10.1074/jbc.M112.359109.
37. Khaitan, D., Dinger, M. E., Mazar, J., Crawford, J., Smith, M. A., Mattick, J. S., et al. (2011). The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 71, 3852-3862. doi: 10.1158/0008-5472.CAN-10-4460.
38. Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., et al. (2013). HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32, 1616-1625. doi: 10.1038/onc.2012.193.
39. Kino, T., Hurt, D. E., Ichijo, T., Nader, N., and Chrousos, G. P. (2010). Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 3, ra8. doi: 10.1126/scisignal.2000568.
40. Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., et al. (2011). Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71, 6320-6326. doi: 10.1158/0008-5472.CAN-11-1021.
41. Koziol, M. J., and Rinn, J. L. (2010). RNA traffic control of chromatin complexes. Curr. Opin. Genet. Dev. 20, 142-148. doi: 10.1016/j.gde.2010.03.003.
42. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403. doi: 10.1016/j.ccr.2006.03.030.
43. Li, L., Dutra, A., Pak, E., Labrie, J. E. III, Gerstein, R. M., Pandolfi, P. P., et al. (2009a). EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neurooncology 11, 9-21. doi: 10.1215/15228517-2008-2081.
44. Li, Y., Guessous, F., Zhang, Y., Dipierro, C., Kefas, B., Johnson, E., et al. (2009b). MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 69, 7569-7576. doi: 10.1158/0008-5472.CAN-09-0529.
45. Lin, M., Pedrosa, E., Shah, A., Hrabovsky, A., Maqbool, S., Zheng, D., et al. (2011). RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS ONE 6:e23356. doi: 10.1371/journal.pone.0023356.
46. Lin, R., Maeda, S., Liu, C., Karin, M., and Edgington, T. S. (2007). A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 26, 851-858. doi: 10.1038/sj.onc.1209846.
47. Lu, K. H., Li, W., Liu, X. H., Sun, M., Zhang, M. L., Wu, W. Q., et al. (2013). Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 13:461. doi: 10.1186/1471-2407-13-461.
48. Lund, A. H., and van Lohuizen, M. (2004). Polycomb complexes and silencing mechanisms. Curr. Opin. Cell Biol. 16, 239-246. doi: 10.1016/j.ceb.2004.03.010.
49. Makeyev, E. V., Zhang, J., Carrasco, M. A., and Maniatis, T. (2007). The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 27, 435-448. doi: 10.1016/j.molcel.2007.07.015.
50. Matouk, I. J., Degroot, N., Mezan, S., Ayesh, S., Abu-Lail, R., Hochberg, A., et al. (2007). The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2:e845. doi: 10.1371/journal.pone.0000845.
51. Mazzoleni, S., Politi, L. S., Pala, M., Cominelli, M., Franzin, A., Sergi Sergi, L., et al. (2010). Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 70, 7500-7513. doi: 10.1158/0008-5472.CAN-10-2353.
52. Medina, P. P., and Slack, F. J. (2008). microRNAs and cancer: an overview. Cell Cycle 7, 2485-2492. doi: 10.4161/cc.7.16.6453.
53. Mercer, T. R., Dinger, M. E., and Mattick, J. S. (2009). Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10, 155-159. doi: 10.1038/nrg2521.
54. Mourtada-Maarabouni, M., Pickard, M., Hedge, V., Farzaneh, F., and Williams, G. (2008). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28, 195-208. doi: 10.1038/onc.2008.373.
55. Muller-Tidow, C., Diederichs, S., Thomas, M., and Serve, H. (2004). Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 45(Suppl. 2), S145-S150. doi: 10.1016/j.lungcan.2004.07.979.
56. Nagano, T., Mitchell, J. A., Sanz, L. A., Pauler, F. M., Ferguson-Smith, A. C., Feil, R., et al. (2008). The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322, 1717-1720. doi: 10.1126/science.1163802.
57. Nager, M., Bhardwaj, D., Canti, C., Medina, L., Nogues, P., and Herreros, J. (2012). Beta-Catenin signalling in glioblastoma multiforme and glioma-initiating cells. Chemother. Res. Pract. 2012, 192362. doi: 10.1155/2012/192362.
58. Natsume, A., Ito, M., Katsushima, K., Ohka, F., Hatanaka, A., Shinjo, K., et al. (2013). Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma. Cancer Res. 73, 4559-4570. doi: 10.1158/0008-5472.CAN-13-0109.
59. Ng, S. Y., Johnson, R., and Stanton, L. W. (2012). Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 31, 522-533. doi: 10.1038/emboj.2011.459.
60. Niinuma, T., Suzuki, H., Nojima, M., Nosho, K., Yamamoto, H., Takamaru, H., et al. (2012). Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 72, 1126-1136. doi: 10.1158/0008-5472.CAN-11-1803.
61. Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., et al. (2008). Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 32, 232-246. doi: 10.1016/j.molcel.2008.08.022.
62. Pasmant, E., Laurendeau, I., Heron, D., Vidaud, M., Vidaud, D., and Bieche, I. (2007). Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963-3969. doi: 10.1158/0008-5472.CAN-06-2004.
63. Pasmant, E., Sabbagh, A., Vidaud, M., and Bieche, I. (2011). ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448. doi: 10.1096/fj.10-172452.
64. Penuelas, S., Anido, J., Prieto-Sanchez, R. M., Folch, G., Barba, I., Cuartas, I., et al. (2009). TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15, 315-327. doi: 10.1016/j.ccr.2009.02.011.
65. Pereira, J. D., Sansom, S. N., Smith, J., Dobenecker, M. W., Tarakhovsky, A., and Livesey, F. J. (2010). Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 107, 15957-15962. doi: 10.1073/pnas.1002530107.
66. Peruzzi, P., Bronisz, A., Nowicki, M. O., Wang, Y., Ogawa, D., Price, R., et al. (2013). MicroRNA-128 coordinately targets polycomb repressor complexes in glioma stem cells. Neurooncology 15, 1212-1224. doi: 10.1093/neuonc/not055.
67. Petrovics, G., Zhang, W., Makarem, M., Street, J. P., Connelly, R., Sun, L., et al. (2004). Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23, 605-611. doi: 10.1038/sj.onc.1207069.
68. Piccirillo, S. G., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., et al. (2006). Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761-765. doi: 10.1038/nature05349.
69. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., and Pandolfi, P. P. (2010). A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033-1038. doi: 10.1038/nature09144.
70. Ponting, C. P., Oliver, P. L., and Reik, W. (2009). Evolution and functions of long noncoding RNAs. Cell 136, 629-641. doi: 10.1016/j.cell.2009.02.006.
71. Popov, N., and Gil, J. (2010). Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 5, 685-690. doi: 10.4161/epi.5.8.12996.
72. Prensner, J. R., and Chinnaiyan, A. M. (2011). The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391-407. doi: 10.1158/2159-8290.CD-11-0209.
73. Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., et al. (2011). Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 29, 742-749. doi: 10.1038/nbt.1914.
74. Reya, T., and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843-850. doi: 10.1038/nature03319.
75. Richly, H., Aloia, L., and Di Croce, L. (2011). Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2, e204. doi: 10.1038/cddis.2011.84.
76. Schickel, R., Boyerinas, B., Park, S., and Peter, M. (2008). MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27, 5959-5974. doi: 10.1038/onc.2008.274.
77. Schor, I. E., Lleres, D., Risso, G. J., Pawellek, A., Ule, J., Lamond, A. I., et al. (2012). Perturbation of chromatin structure globally affects localization and recruitment of splicing factors. PLoS ONE 7:e48084. doi: 10.1371/journal.pone.0048084.
78. Shi, X., Sun, M., Liu, H., Yao, Y., and Song, Y. (2013). Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 339, 159-166. doi: 10.1016/j.canlet.2013.06.013.
79. Shih, A. H., and Holland, E. C. (2006). Notch signaling enhances nestin expression in gliomas. Neoplasia 8, 1072-1082. doi: 10.1593/neo.06526.
80. Silber, J., Lim, D. A., Petritsch, C., Persson, A. I., Maunakea, A. K., Yu, M., et al. (2008). miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:14. doi: 10.1186/1741-7015-6-14.
81. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature 432, 396-401. doi: 10.1038/nature03128.
82. Srikantan, V., Zou, Z., Petrovics, G., Xu, L., Augustus, M., Davis, L., et al. (2000). PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 97, 12216-12221. doi: 10.1073/pnas.97.22.12216.
83. Suva, M. L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J. C., et al. (2009). EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 69, 9211-9218. doi: 10.1158/0008-5472.CAN-09-1622.
84. Takayama, K. -I., Horie-Inoue, K., Katayama, S., Suzuki, T., Tsutsumi, S., Ikeda, K., et al. (2013). Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J. 32, 1665-1680. doi: 10.1038/emboj.2013.99.
85. Takebe, N., Harris, P. J., Warren, R. Q., and Ivy, S. P. (2011). Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat. Rev. Clin. Oncol. 8, 97-106. doi: 10.1038/nrclinonc.2010.196.
86. Takezaki, T., Hide, T., Takanaga, H., Nakamura, H., Kuratsu, J., and Kondo, T. (2011). Essential role of the Hedgehog signaling pathway in human glioma-initiating cells. Cancer Sci. 102, 1306-1312. doi: 10.1111/j.1349-7006.2011.01943.x.
87. Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., et al. (2010). MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584, 4575-4580. doi: 10.1016/j.febslet.2010.10.008.
88. Tian, D., Sun, S., and Lee, J. T. (2010). The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation. Cell 143, 390-403. doi: 10.1016/j.cell.2010.09.049.
89. Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., et al. (2010). The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925-938. doi: 10.1016/j.molcel.2010.08.011.
90. Wang, J., Wakeman, T. P., Lathia, J. D., Hjelmeland, A. B., Wang, X. F., White, R. R., et al. (2010). Notch promotes radioresistance of glioma stem cells. Stem Cells 28, 17-28. doi: 10.1002/stem.261.
91. Wang, K. C., Yang, Y. W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y., et al. (2011). A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472, 120-124. doi: 10.1038/nature09819.
92. Wang, P., Ren, Z., and Sun, P. (2012). Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J. Cell. Biochem. 113, 1868-1874. doi: 10.1002/jcb.24055.
93. Wapinski, O., and Chang, H. Y. (2011). Long noncoding RNAs and human disease. Trends Cell Biol. 21, 354-361. doi: 10.1016/j.tcb.2011.04.001.
94. Wen, P. Y., and Kesari, S. (2008). Malignant gliomas in adults. N. Engl. J. Med. 359, 492-507. doi: 10.1056/NEJMra0708126.
95. Wu, Q., Kim, Y. C., Lu, J., Xuan, Z., Chen, J., Zheng, Y., et al. (2008). Poly A- transcripts expressed in HeLa cells. PLoS ONE 3:e2803. doi: 10.1371/journal.pone.0002803.
96. Xia, H., Cheung, W. K., Ng, S. S., Jiang, X., Jiang, S., Sze, J., et al. (2012). Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J. Biol. Chem. 287, 9962-9971. doi: 10.1074/jbc.M111.332627.
97. Yang, Z., Zhou, L., Wu, L. M., Lai, M. C., Xie, H. Y., Zhang, F., et al. (2011). Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 18, 1243-1250. doi: 10.1245/s10434-011-1581-y.
98. Ying, Z., Li, Y., Wu, J., Zhu, X., Yang, Y., Tian, H., et al. (2013). Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res. 73, 990-999. doi: 10.1158/0008-5472.CAN-12-2895.
99. Yu, M., Ohira, M., Li, Y., Niizuma, H., Oo, M. L., Zhu, Y., et al. (2009). High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int. J. Oncol. 34, 931-938. doi: 10.3892/ijo_00000219.
100. Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A. P., et al. (2008). Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202-206. doi: 10.1038/nature06468.
101. Zhang, H., Chen, Z., Wang, X., Huang, Z., He, Z., and Chen, Y. (2013). Long non-coding RNA: a new player in cancer. J. Hematol. Oncol. 6, 37. doi: 10.1186/1756-8722-6-37.
102. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J., and Lee, J. T. (2008). Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756. doi: 10.1126/science.1163045.
103. Zhou, Y., Zhang, X., and Klibanski, A. (2012). MEG3 noncoding RNA: a tumor suppressor. J. Mol. Endocrinol. 48, R45-R53. doi: 10.1530/JME-12-18.
104. Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., et al. (2007). Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 282, 24731-24742. doi: 10.1074/jbc.M702029200.
105. Zhu, Y., Yu, M., Li, Z., Kong, C., Bi, J., Li, J., et al. (2011). ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. Urology 77, 510 e511-e515. doi: 10.1016/j.urology.2010.09.022.